Anualidad

Anualidad RDF

páginas:

AB0237 WHAT DO SPANISH RHEUMATOLOGISTS THINK ABOUT THE EFFICACY OF THE DRUGS USED IN THE MANAGEMENT OF PATIENT WITH RHEUMATOID ARTHRITIS AND POOR PROGNOSIS FACTORS? PROGRESAR-2 PROJECT Conference Poster 2019 Congress communication
AB0253 Identification of factors associated with a worse outcome -exitus- in patients with rheumatoid arthritis and severe infection Conference Poster 2023 Congress communication
AB0319 -ABATACEPT IN RHEUMATOID ARTHRITIS WITH INTERSTITIAL LUNG DISEASE. A MULTICENTRE STUDY OF 181 PATIENTS Conference Poster 2019 Congress communication
AB0473 Hypogammaglobulinemia and infections in rheumatologic patients treated with rituximab. Conference Poster 2019 Congress communication
AB0473. Hypogammaglobulinemia and infections in rheumatologic patients treated with rituximab. Conference Poster 2019 Congress communication
AB0577 TOCILIZUMAB IN GIANT CELL ARTERITIS. ROUTE OF ADMINISTRACION: INTRAVENOUS OR SUBCUTANEOUS Conference Poster 2019 Congress communication
AB0707. Predictive factors of relapse in giant cell arteritis treated with tocilizumab Conference Poster 2023 Congress communication
AB0760 Evolution of patients with giant cell arteritis: before and after the biological era Conference Poster 2023 Congress communication
AB0858. MAINLY MEN, AND OLDER PEOPLE, WITH FRAGILITY HIP FRACTURE DO NOT RECEIVE ANTIOSTEOPOROTIC TREATMENT Conference Poster 2019 Congress communication
AB0865. Gout in hospitalised patients for cardiovascular diseases: prevalence and management status. Conference Poster 2019 Congress communication
AB1002VF Grant 2016 Research Project
AB1004VF Grant 2018 Research Project
AB1005VF Grant 2019 Research Project
AB1006IP Grant 2020 2021 Research Project
ABA y ApS: innovando, aprendiendo, adquiriendo competencias y ¡reciclando material de escritura! Una experiencia educativa de marketing social Chapter 2019
ABA-dependent Gene Regulation of Tomato Plants in Response to Spider Mite (Tetranychus urticae) Conference Poster 2024 Congress communication
Abacavir once or twice daily combined with once-daily lamivudine and efavirenz for the treatment of antiretroviral-naive HIV-infected adults: results of the Ziagen Once Daily in Antiretroviral Combination Study. Academic Article 2005
Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction Academic Article 2010
Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study Academic Article 2016
Abadías laberintos y pixeles. Narrativas transmedia desde El Nombre de la rosa Book 2024
ABAG1.08PT Grant 2008 Thrid Party Project
Abandonarse al camino Academic Article 2018
Abandono precoz y persistencia en la práctica del baloncesto federado: una perspectiva de género Chapter 2024
Abandono y baja adhesión en intervenciones conductuales de pérdida de peso: una propuesta para su evaluación Conference Poster 2022 Congress communication
Abandono y retirada deportiva Chapter 2006
ABATACEPT EN ENFERMEDAD PULMONAR INTERSTICIAL ASOCIADA A ARTRITIS REUMATOIDE. ESTUDIO MULTICENTRO NACIONAL DE 263 PACIENTES Conference Poster 2020 Congress communication
ABATACEPT EN NEUMONÍA INTERSTICIAL USUAL Y EN NEUMONÍA INTERSTICIAL NO ESPECÍFICA ASOCIADAS A ARTRITIS REUMATOIDE. ESTUDIO NACIONAL MULTICÉNTRICO DE 190 PACIENTES Conference Poster 2021 Congress communication
ABATACEPT IN COMBINATION WITH METOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS ASSOCIATED TO INTERSTITIAL LUNG DISEASE: NATIONAL MULTICENTER STUDY OF 263 PATIENTS Conference Poster 2020 Congress communication
ABATACEPT IN INTERSTITIAL LUNG DISEASE ASSOCIATED WITH RHEUMATOID ARTHRITIS. NATIONAL MULTICENTER STUDY OF 263 PATIENTS Conference Paper 2020 Congress communication
Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients Academic Article 2020

páginas: